This website uses cookies to enhance the user experience.
C

CHIRON PHARMASYNTH AS983 903 827

Process industry
Limited company
Arkitekt Ebbells veg 26 7041 TRONDHEIM, Norge
Industry and manufacturing
/ Process industry

CHIRON PHARMASYNTH AS

Keywords

productionmedicinal substancesdrugsantibioticsbasic vitaminssalicylic acido-acetylsalicylic acidprocessing of blood

Links

Organization

CEO
MS

Marianne Sinnes1969

Chairman of the board
JO

Jonathan Otto Salkin1970

Years since formation
24 years
since Nov 17, 2001
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
100,000
1 share class
Total number of shareholders
1
company
Belongs to group of

Financials

Total operating income 2023
23,983,984
NOK
Annual total result 2023
4,290,755
NOK
Total equity 2023
19,117,790
NOK
Last update: Aug 29, 2024

Management

Management / administration

NameRoleShares
MS

Marianne Sinnes

1969

Managing Director/CEO-

Board

NameRoleShares
JO

Jonathan Otto Salkin

1970

Chairman-
PR

Philip Rinaldi

1963

Board Member-
MS

Marianne Sinnes

1969

Board Member-

Others

NameRoleShares
P
PRICEWATERHOUSECOOPERS AS
Auditor-
Ø
ØKONOMISENTERET AS
Accountant-
Last update: Mar 19, 2024

Ownership

Company shareholders

NameShare classNumber of sharesShare
C
CHIRON AS
Ordinary shares
100,000
100 %
Last update: May 24, 2024

Group structure

Financials

in NOK

Summary

Year202320222021
Total operating income
23,983,984
15,919,267
10,926,390
Annual Total Result
4,290,755
1,805,539
3,292,183
Total assets
32,931,220
28,458,061
25,541,100
Total liabilities
13,813,430
10,880,072
9,768,649
Total equity
19,117,790
17,577,989
15,772,451

P&L

Year202320222021
Total operating income
23,983,984
15,919,267
10,926,390
Total operating costs
19,021,274
14,272,185
7,090,802
Operating result
4,962,710
1,647,081
3,835,589
Financial income/costs
103,956
245,644
8,978
Profit before tax
5,066,666
1,892,726
3,844,567
Total tax & extraordinary income/cost
775,911
87,187
552,384
Annual Total Result
4,290,755
1,805,539
3,292,183

Balance overview

Year202320222021
Total fixed assets
0
0
0
Total current assets
32,931,220
28,458,061
25,541,100
Total assets
32,931,220
28,458,061
25,541,100
Short term debt
13,813,430
10,880,072
9,768,649
Long term debt
0
0
0
Total liabilities
13,813,430
10,880,072
9,768,649
Contributed capital
1,775,000
1,775,000
1,775,000
Retained earnings
17,342,790
15,802,989
13,997,451
Total equity
19,117,790
17,577,989
15,772,451
Total equity and liabilities
32,931,220
28,458,061
25,541,100

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
C
Main industrial area
Manufacturing
21
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.1
Main industrial group
Manufacture of basic pharmaceutical products
21.10
Industrial group
Manufacture of basic pharmaceutical products
21.100
Industrial group
Manufacture of basic pharmaceutical products